Bank of America’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Bank of America’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-26,800	Closed	-$1.82M	–	8784
2022 Q3	$1.82M	Sell	26,800 -3,200	-11%	-$176K	﹤0.01%	4368
2022 Q2	$958K	Buy	+30,000	New	+$878K	﹤0.01%	4954
2018 Q3	–	Sell	-274,800	Closed	-$12.4M	–	7549
2018 Q2	$12.4M	Buy	274,800 +74,400	+37%	+$3.39M	﹤0.01%	2243
2018 Q1	$9.68M	Buy	200,400 +102,400	+104%	+$5.71M	﹤0.01%	2441
2017 Q4	$3.86M	Buy	+98,000	New	+$3.66M	﹤0.01%	3358

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Bank of America's GBT Position: Q4 2022 in Review

Bank of America sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 149,118 shares — an estimated $10.2M sold.

Bank of America first reported a position in GBT in Q3 2015 and held it in 29 quarters. The position peaked at $375M in Q4 2019. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

Bank of America reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
Bank of America sold 149,118 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $10.2M.
Bank of America first reported a position in Global Blood Therapeutics, Inc. in Q3 2015 and held it in 29 quarters.
Bank of America's Global Blood Therapeutics, Inc. position peaked at $375M in Q4 2019.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Bank of America's 13F filing for Q4 2022, filed 10 Feb 2023.